Skip to main content

Ep. 6: “Precision Cancer Immunotherapy” Featuring Dr. Daniela Thommen

By June 8, 2021January 9th, 2023No Comments

Daniela Thommen


Dr. Daniela Thommen is a Group Leader at the Netherlands Cancer Institute. Her lab is interested in understanding how human cancers immunologically respond to treatment, and how such responses relate to the immunological makeup of a tumor.

Featured Products and Resources:

The Immunology Science Round Up

Immunity against COVID-19 Variants of Concern – T cell-mediated immunity against SARS-CoV-2 is not affected by the mutations in the B.1.1.7 and B.1.351 variants.

Atypical B Cells in Chronic Infectious Diseases – Researchers used single-cell RNA sequencing to analyze atypical B cells in malaria, HIV, and autoimmune diseases, and found similar transcriptional profiles.

Immune Development in Mucosal Tissues – Scientists showed that embryonic macrophages prepare the colon for colonization by invariant natural killer T cells in the days after birth.

A Vaccine for Trypanosomes – Researchers used a genome-led approach to identify a vaccine candidate for Trypanosoma vivax, a deadly parasite that can infect humans and livestock.

Photo Reference: Courtesy of Dr. Daniela Thommen

Subscribe to our newsletter!

Never miss updates about new episodes.